Såranalyse.dk ApS: Financial statements 2023
CVR: 32661971
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Såranalyse.dk ApS (CVR 32661971) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -8,309 and a net result of DKK -3,093 compared with DKK -22,820 the year before. Equity in the 2023 report amounted to DKK 226,810. The solvency ratio was 56.4%.
- Gross Profit
- DKK -8,309
- Profit/Loss
- DKK -3,093
- Equity
- DKK 226,810
- Total Assets
- DKK 402,340
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -8 t. | -3 t. | 227 t. | - |
| 2022 | 0 | -7 t. | -23 t. | 230 t. | - |
| 2021 | - | -7 t. | -11 t. | 253 t. | - |
| 2020 | - | -9 t. | -2 t. | 264 t. | - |
| 2019 | - | -6 t. | 3 t. | 266 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Såranalyse.dk ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -22,820.
About Såranalyse.dk ApS
Såranalyse.dk ApS was a Danish company of the type Anpartsselskab based in Ugerløse, founded in 2009. The company has been dissolved on 10 August 2026. The company was registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named SUSAN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -20,744 and a net result of DKK -297,616 compared with DKK -2,153 the year before. Equity in the 2025 report amounted to DKK -72,959.